EPIX [NASD]
ESSA Pharma Inc.
Index- P/E- EPS (ttm)-0.86 Insider Own11.30% Shs Outstand44.03M Perf Week-3.51%
Market Cap239.42M Forward P/E- EPS next Y-1.37 Insider Trans-0.51% Shs Float41.15M Perf Month-6.46%
Income-37.30M PEG- EPS next Q-0.28 Inst Own86.10% Short Float6.09% Perf Quarter-32.68%
Sales- P/S- EPS this Y8.40% Inst Trans-0.32% Short Ratio9.86 Perf Half Y-60.20%
Book/sh4.06 P/B1.35 EPS next Y-30.10% ROA-19.20% Target Price31.40 Perf Year-82.61%
Cash/sh4.16 P/C1.32 EPS next 5Y- ROE-19.60% 52W Range5.22 - 33.84 Perf YTD-61.27%
Dividend- P/FCF- EPS past 5Y37.20% ROI- 52W High-83.75% Beta1.54
Dividend %- Quick Ratio48.60 Sales past 5Y- Gross Margin- 52W Low5.47% ATR0.49
Employees30 Current Ratio48.60 Sales Q/Q- Oper. Margin- RSI (14)40.65 Volatility7.10% 9.06%
OptionableYes Debt/Eq0.00 EPS Q/Q30.60% Profit Margin- Rel Volume1.02 Prev Close5.30
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume254.06K Price5.50
Recom- SMA20-4.49% SMA50-12.59% SMA200-39.58% Volume259,699 Change3.77%
Mar-04-21Initiated Piper Sandler Overweight $50
Jan-11-21Reiterated H.C. Wainwright Buy $10 → $17
Nov-02-20Initiated Jefferies Buy $17
Oct-25-19Initiated Oppenheimer Outperform $8
May-27-22 08:12AM  
May-10-22 07:00AM  
Apr-26-22 04:30PM  
04:30PM  
Apr-25-22 10:20AM  
Apr-08-22 01:00PM  
Mar-10-22 04:05PM  
Mar-09-22 11:34PM  
11:34PM  
Mar-08-22 04:30PM  
04:30PM  
Feb-04-22 05:16AM  
Feb-03-22 07:00AM  
07:00AM  
Jan-19-22 07:00AM  
Dec-28-21 09:38AM  
Dec-21-21 09:38AM  
Dec-16-21 09:38AM  
Dec-11-21 05:38AM  
Dec-08-21 09:38AM  
Nov-22-21 09:20AM  
Nov-18-21 07:00AM  
Nov-08-21 07:00AM  
07:00AM  
Oct-28-21 04:05PM  
04:05PM  
Oct-19-21 01:21PM  
Oct-07-21 10:25AM  
09:00AM  
06:30AM  
Aug-31-21 04:05PM  
04:05PM  
Aug-24-21 06:30AM  
04:30AM  
Aug-16-21 02:32PM  
12:13PM  
10:22AM  
07:00AM  
07:00AM  
Jul-13-21 12:38PM  
May-25-21 07:00AM  
May-10-21 10:59AM  
May-06-21 07:01AM  
07:01AM  
Apr-28-21 07:00AM  
07:00AM  
Apr-14-21 07:00AM  
07:00AM  
Apr-12-21 10:50AM  
Apr-10-21 08:30AM  
08:30AM  
Mar-26-21 04:05PM  
04:05PM  
Mar-04-21 11:32AM  
11:32AM  
Mar-02-21 08:00AM  
Feb-25-21 06:33PM  
04:30PM  
04:30PM  
07:00AM  
Feb-22-21 11:48AM  
11:48AM  
Feb-17-21 10:47PM  
Feb-16-21 04:01PM  
08:30AM  
Feb-12-21 04:40AM  
Feb-11-21 10:38AM  
08:02AM  
08:02AM  
07:00AM  
07:00AM  
Feb-05-21 04:53PM  
Jan-13-21 07:00AM  
07:00AM  
Jan-08-21 02:50PM  
Dec-17-20 06:27AM  
Dec-15-20 07:50PM  
05:01PM  
05:01PM  
Dec-08-20 09:14AM  
Nov-25-20 07:00AM  
Nov-13-20 12:58PM  
Nov-10-20 07:00AM  
Oct-26-20 05:01PM  
Oct-24-20 07:18PM  
Oct-19-20 07:00AM  
07:00AM  
Sep-21-20 07:00AM  
07:00AM  
Sep-17-20 05:05PM  
Sep-14-20 07:00AM  
Sep-10-20 07:00AM  
Aug-12-20 09:22AM  
Aug-07-20 06:16AM  
Aug-06-20 08:00PM  
Jul-31-20 10:16AM  
Jul-28-20 09:18PM  
04:01PM  
Jul-17-20 09:37AM  
Jul-15-20 07:00AM  
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BIOTECH GROWTH N V10% OwnerApr 27Sale5.8525,100146,9254,990,714Apr 28 12:28 PM
BIOTECH GROWTH N V10% OwnerAug 18Buy8.88250,0002,218,8005,015,814Aug 20 12:43 PM